General Information of the Compound
Compound ID
CP0403268
Compound Name
N-[(2R)-3-(4-chlorophenyl)-1-oxo-1-[4-[2-[(2-thiophen-2-ylethylamino)methyl]phenyl]piperazin-1-yl]propan-2-yl]pyridine-3-carboxamide
    Show/Hide
Structure
Formula
C32H34ClN5O2S
Molecular Weight
588.177
Canonical SMILES
Clc1ccc(C[C@@H](NC(=O)c2cccnc2)C(=O)N2CCN(CC2)c2ccccc2CNCCc2cccs2)cc1
    Show/Hide
InChI
InChI=1S/C32H34ClN5O2S/c33-27-11-9-24(10-12-27)21-29(36-31(39)26-6-3-14-34-23-26)32(40)38-18-16-37(17-19-38)30-8-2-1-5-25(30)22-35-15-13-28-7-4-20-41-28/h1-12,14,20,23,29,35H,13,15-19,21-22H2,(H,36,39)/t29-/m1/s1
    Show/Hide
InChIKey
KCOGRZRTHYZEQU-GDLZYMKVSA-N
Physicochemical Property
logP
4.8187
Rotatable Bonds
11
Heavy Atom Count
41
Polar Areas
77.57
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396002
ChEMBL ID
CHEMBL364215
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01325, Melanocortin receptor 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 1800 nM
   TI
   LI
   LO
   TS
Protein ID: PT00914, Melanocortin receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 41 nM
   TI
   LI
   LO
   TS
Protein ID: PT01804, Melanocortin receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 730 nM
   TI
   LI
   LO
   TS